Sign in

    Kaplan Ling

    Research Analyst at Essence Securities

    Kaplan Ling is a Research Analyst at Essence Securities with a focus on equity research, actively participating in earnings calls and covering companies such as Akso Health. While Ling's public track record details are limited, available data indicate direct engagement with company management through question participation in financial results briefings. Ling's tenure and previous industry experience prior to joining Essence Securities are not extensively documented, suggesting a recent entry or a discreet research role within the firm. Specific professional credentials, securities licenses, or industry certifications for Ling are not publicly listed at this time.

    Kaplan Ling's questions to Akso Health (AHG) leadership

    Kaplan Ling's questions to Akso Health (AHG) leadership • Q3 2019

    Question

    Kaplan Ling from Essence Securities requested the company's outlook for the upcoming fiscal year concerning loan volume, borrower, and lender growth. He also asked about Hexindai's mergers and acquisitions strategy and its primary areas of focus.

    Answer

    CEO Xinming Zhou stated that guidance for the next fiscal year would be issued on the following earnings call. Regarding M&A, Mr. Zhou confirmed the company will continue to seek investment opportunities in the online lending business, highlighting its recent investments in an Indonesian platform and Phoenix Intelligent Credit, with a strategic focus on emerging markets like Southeast Asia.

    Ask Fintool Equity Research AI